Shareholder alert: weiss law investigates biohaven pharmaceutical holding company ltd.

New york , may 10, 2022 /prnewswire/ -- weiss law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of biohaven pharmaceutical holding company ltd. ("biohaven" or the "company") (nyse: bhvn) in connection with the proposed acquisition of the company by pfizer inc. ("pfizer") (nyse: pfe).

BHVN Ratings Summary

BHVN Quant Ranking